| Net Cash Provided by (Used in) Operating Activities |
76.1M |
USD |
+10.8% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
30.6M |
USD |
+141% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
-100M |
USD |
-40.8% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
431M |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
137M |
shares |
+0.38% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
6.69M |
USD |
-35.4% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
11.8M |
USD |
-48.8% |
Q3 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
148K |
USD |
+771% |
Q1 2023 |
Q1 2023 |
| Deferred Tax Assets, Valuation Allowance |
0 |
USD |
|
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Gross |
27.3M |
USD |
+54.4% |
Q4 2024 |
FY 2024 |
| Deferred Income Tax Expense (Benefit) |
2.87M |
USD |
-40.5% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
14.2M |
USD |
+3.47% |
Q4 2024 |
FY 2024 |
| Unrecognized Tax Benefits |
0 |
USD |
|
Q3 2025 |
Q3 2025 |
| Additional Paid in Capital |
658M |
USD |
+0.46% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
27.3M |
USD |
+54.4% |
Q4 2024 |
FY 2024 |
| Share-based Payment Arrangement, Expense |
3M |
USD |
+117% |
Q3 2025 |
Q3 2025 |
| Interest Expense |
8.14M |
USD |
+351% |
Q1 2024 |
Q1 2024 |